• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实用的乳腺癌细胞动力学:综述与更新

Practical breast carcinoma cell kinetics: review and update.

作者信息

Meyer J S, McDivitt R W, Stone K R, Prey M U, Bauer W C

出版信息

Breast Cancer Res Treat. 1984;4(2):79-88. doi: 10.1007/BF01806389.

DOI:10.1007/BF01806389
PMID:6378283
Abstract

The S-phase fraction (SP) measured by flow cytometry of DNA and the thymidine labeling index (TLI) measured autoradiographically indicate the proportion of carcinoma cells currently synthesizing DNA and reflect the rate of proliferation. The TLI and SPF are lognormally distributed. The median TLI performed to maximize precursor uptake is near 5% (5 labeled carcinoma cells per 100) the mean near 7%, and the range from less than 1% to near 40%. Corresponding values for the SPF measured by DNA flow cytometry are slightly higher when appropriate measures are taken to reduce background debris counts and other artefacts. Residual elevation of SPF above TLI may result from S-phase arrested cells. Flow cytometric histograms show that clearly aneuploid cell lines exist in 50-80% of primary breast carcinomas. Aneuploid breast carcinomas have higher mean TLI than diploid breast carcinomas, and therefore proliferate more rapidly. They also more frequently lack estrogen receptor (ER). Carcinomas with minimal nuclear anaplasia, particularly those of tubular, mucinous, infiltrating lobular and adenocystic types have low TLI and SPF, whereas carcinomas with highly anaplastic nuclei, including medullary carcinomas, have high TLI and SPF. TLI and SPF correlate inversely with ER and PgR content, have no relationship to axillary lymph nodal status, and have a weak positive correlation with tumor size and a weak negative correlation with age. High TLI predicts a high risk of early relapse after primary therapy for both node-negative and node-positive carcinomas. Carcinomas that produce brain metastases have particularly high TLI. Current evidence suggests that high SPF and aneuploidy may prove to have prognostic significance like TLI.

摘要

通过DNA流式细胞术测量的S期分数(SP)和通过放射自显影术测量的胸苷标记指数(TLI)表明当前正在合成DNA的癌细胞比例,并反映增殖速率。TLI和SPF呈对数正态分布。为使前体摄取最大化而进行的TLI中位数接近5%(每100个中有5个标记的癌细胞),平均值接近7%,范围从小于1%到接近40%。当采取适当措施减少背景碎片计数和其他假象时,通过DNA流式细胞术测量的SPF相应值略高。SPF高于TLI的残余升高可能源于S期停滞细胞。流式细胞术直方图清楚地显示,50 - 80%的原发性乳腺癌中存在明显的非整倍体细胞系。非整倍体乳腺癌的平均TLI高于二倍体乳腺癌,因此增殖更快。它们也更频繁地缺乏雌激素受体(ER)。核间变最小的癌,特别是管状、黏液性、浸润性小叶和腺囊性类型的癌,TLI和SPF较低,而核高度间变的癌,包括髓样癌,TLI和SPF较高。TLI和SPF与ER和PgR含量呈负相关,与腋窝淋巴结状态无关,与肿瘤大小呈弱正相关,与年龄呈弱负相关。高TLI预测原发性治疗后无论是淋巴结阴性还是阳性的癌早期复发风险都高。发生脑转移的癌TLI特别高。目前的证据表明,高SPF和非整倍体可能与TLI一样具有预后意义。

相似文献

1
Practical breast carcinoma cell kinetics: review and update.实用的乳腺癌细胞动力学:综述与更新
Breast Cancer Res Treat. 1984;4(2):79-88. doi: 10.1007/BF01806389.
2
S-phase fraction and nuclear size in long term prognosis of patients with breast cancer.乳腺癌患者长期预后中的S期分数与细胞核大小
Cancer. 1994 Oct 15;74(8):2287-99. doi: 10.1002/1097-0142(19941015)74:8<2287::aid-cncr2820740813>3.0.co;2-y.
3
DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens.1331例冷冻乳腺癌标本的DNA流式细胞术及预后因素
Cancer. 1988 Feb 1;61(3):420-7. doi: 10.1002/1097-0142(19880201)61:3<420::aid-cncr2820610303>3.0.co;2-0.
4
S-phase fractions of breast carcinomas. Relationships to morphology, estrogen and progesterone receptors, and early recurrence.乳腺癌的S期分数。与形态学、雌激素和孕激素受体以及早期复发的关系。
Bull Cancer. 1978;65(4):449-54.
5
A proposed classification of breast cancer based on kinetic information: derived from a comparison of risk factors in 168 primary operable breast cancers.一种基于动力学信息的乳腺癌分类方法:源自对168例原发性可手术乳腺癌危险因素的比较。
Cancer. 1986 Jan 15;57(2):269-76. doi: 10.1002/1097-0142(19860115)57:2<269::aid-cncr2820570214>3.0.co;2-d.
6
Thymidine labeling index, flow cytometric S-phase measurement, and DNA index in human tumors. Comparisons and correlations.人肿瘤中的胸苷标记指数、流式细胞术S期测量及DNA指数。比较与相关性
Am J Clin Pathol. 1988 May;89(5):586-95. doi: 10.1093/ajcp/89.5.586.
7
Aneuploid DNA content and high S-phase fraction of tumour cells are related to poor prognosis in patients with primary breast cancer.非整倍体DNA含量和肿瘤细胞的高S期分数与原发性乳腺癌患者的不良预后相关。
Eur J Cancer Clin Oncol. 1987 Mar;23(3):277-82. doi: 10.1016/0277-5379(87)90071-x.
8
Regional heterogeneity in breast carcinoma: thymidine labelling index, steroid hormone receptors, DNA ploidy.乳腺癌的区域异质性:胸腺嘧啶核苷标记指数、类固醇激素受体、DNA倍体
Int J Cancer. 1991 Jan 21;47(2):213-20. doi: 10.1002/ijc.2910470209.
9
Proliferative index of breast carcinoma by thymidine labeling: prognostic power independent of stage, estrogen and progesterone receptors.通过胸腺嘧啶核苷标记法检测乳腺癌的增殖指数:独立于分期、雌激素和孕激素受体的预后价值
Breast Cancer Res Treat. 1988 Oct;12(2):191-204. doi: 10.1007/BF01805940.
10
Cell kinetic analysis of human breast carcinomas.
Monogr Pathol. 1984(25):45-58.

引用本文的文献

1
The proliferation rate paradox in antimitotic chemotherapy.抗有丝分裂化疗中的增殖率悖论。
Mol Biol Cell. 2012 Jan;23(1):1-6. doi: 10.1091/mbc.E10-04-0335.
2
Proliferation of the breast epithelium in relation to menstrual cycle phase, hormonal use, and reproductive factors.
Breast Cancer Res Treat. 1996;40(2):187-96. doi: 10.1007/BF01806214.
3
Correlation of growth fraction by Ki-67 and proliferating cell nuclear antigen (PCNA) immunohistochemistry with histopathological parameters and prognosis in primary breast carcinomas.原发性乳腺癌中通过Ki-67和增殖细胞核抗原(PCNA)免疫组织化学检测的生长分数与组织病理学参数及预后的相关性

本文引用的文献

1
THE ORGANIZATION AND DUPLICATION OF CHROMOSOMES AS REVEALED BY AUTORADIOGRAPHIC STUDIES USING TRITIUM-LABELED THYMIDINEE.利用氚标记胸腺嘧啶核苷放射自显影研究揭示的染色体的组织与复制
Proc Natl Acad Sci U S A. 1957 Jan 15;43(1):122-8. doi: 10.1073/pnas.43.1.122.
2
Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years.乳腺癌的组织学分级与预后;对1409例病例的研究,其中359例已随访15年。
Br J Cancer. 1957 Sep;11(3):359-77. doi: 10.1038/bjc.1957.43.
3
Relationship between nuclear DNA distribution and estrogen receptors in human mammary carcinomas.
Breast Cancer Res Treat. 1996;37(2):101-13. doi: 10.1007/BF01806492.
4
Proliferating cell nuclear antigen in breast carcinomas. An immunohistochemical study with correlation to histopathological features and prognostic factors.乳腺癌中的增殖细胞核抗原。一项与组织病理学特征及预后因素相关的免疫组织化学研究。
Virchows Arch. 1994;424(1):39-46. doi: 10.1007/BF00197391.
5
Prognostic value of the combined assessment of proliferating cell nuclear antigen immunostaining and nuclear DNA content in invasive human mammary carcinomas.
Virchows Arch A Pathol Anat Histopathol. 1993;423(4):273-9. doi: 10.1007/BF01606890.
6
Relationship of flow cytometry results to clinical and steroid receptor status in human breast cancer.
Breast Cancer Res Treat. 1985;6(2):113-21. doi: 10.1007/BF02235742.
7
A comparison of static cytofluorometry and flow cytometry for the estimation of ploidy and DNA replication in human breast cancer.用于评估人类乳腺癌倍性和DNA复制的静态细胞荧光测定法与流式细胞术的比较
Breast Cancer Res Treat. 1986;7(1):15-22. doi: 10.1007/BF01886731.
8
The DNA labelling index: a prognostic factor in node-negative breast cancer.
Breast Cancer Res Treat. 1987;9(3):207-11. doi: 10.1007/BF01806381.
9
The predictive value of positive test results in screening for breast cancer by mammography in the Nijmegen programme.奈梅亨项目中乳腺钼靶筛查乳腺癌时阳性检测结果的预测价值。
Br J Cancer. 1987 Nov;56(5):667-71. doi: 10.1038/bjc.1987.263.
10
Apocrine carcinoma of the breast--a case report.乳腺大汗腺癌——病例报告
Jpn J Surg. 1988 Nov;18(6):714-7. doi: 10.1007/BF02471535.
人类乳腺癌中核DNA分布与雌激素受体之间的关系。
Anal Quant Cytol. 1980 Dec;2(4):280-4.
4
Relationship between primary breast tumor receptor status and patient survival.原发性乳腺肿瘤受体状态与患者生存率之间的关系。
Cancer. 1980 Dec 15;46(12 Suppl):2765-9. doi: 10.1002/1097-0142(19801215)46:12+<2765::aid-cncr2820461404>3.0.co;2-c.
5
The cell cycle kinetics of human breast cancer.
Cancer. 1980 Dec 15;46(12):2634-9. doi: 10.1002/1097-0142(19801215)46:12<2634::aid-cncr2820461217>3.0.co;2-k.
6
Relationships of S-phase fraction of breast carcinoma in relapse to duration of remission, estrogen receptor content, therapeutic responsiveness, and duration of survival.
Cancer Res. 1980 Jun;40(6):1890-6.
7
Flow microfluorometric deoxyribonucleic acid (DNA) analysis supplementing routine histopathologic diagnosis of biopsy specimens.流式微量荧光脱氧核糖核酸(DNA)分析辅助活检标本的常规组织病理学诊断。
Lab Invest. 1980 Jan;42(1):85-90.
8
Relationship among estrogen receptors, proliferative activity and menopausal status in breast cancer.
Breast Cancer Res Treat. 1981;1(3):253-62. doi: 10.1007/BF01806265.
9
Flow cytometry of breast carcinoma: II. Relation of tumor cell cycle distribution to histology and estrogen receptor.乳腺癌的流式细胞术:II. 肿瘤细胞周期分布与组织学及雌激素受体的关系
Cancer. 1981 Aug 15;48(4):985-8. doi: 10.1002/1097-0142(19810815)48:4<985::aid-cncr2820480422>3.0.co;2-q.
10
Flow cytometry of breast carcinoma: I. Relation of DNA ploidy level to histology and estrogen receptor.乳腺癌的流式细胞术:I. DNA倍体水平与组织学及雌激素受体的关系
Cancer. 1981 Aug 15;48(4):980-4. doi: 10.1002/1097-0142(19810815)48:4<980::aid-cncr2820480421>3.0.co;2-7.